OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology
Zhongfeng Ye, Joseph F. Harmon, Wei Ni, et al.
ACS Nano (2023) Vol. 17, Iss. 16, pp. 15231-15253
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Liposomes, transfersomes and niosomes: production methods and their applications in the vaccinal field
Domenico Riccardi, Lucia Baldino, Ernesto Reverchon
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 24

Interactions between nanoparticles and lymphatic systems: Mechanisms and applications in drug delivery
Yisi Tang, Bao Liu, Yuting Zhang, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115304-115304
Closed Access | Times Cited: 17

mRNA Cancer Vaccines: Construction and Boosting Strategies
Xiaoqing Liu, Pei Huang, Rusen Yang, et al.
ACS Nano (2023) Vol. 17, Iss. 20, pp. 19550-19580
Closed Access | Times Cited: 37

mRNA nanodelivery systems: targeting strategies and administration routes
Mujie Yuan, Zeyu Han, Yan Liang, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 28

Enhancing RNA-lipid nanoparticle delivery: Organ- and cell-specificity and barcoding strategies
Pu-Sheng Wei, Nagasri Thota, Gresham John, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 366-388
Open Access | Times Cited: 9

Research progress on the quality control of mRNA vaccines
Chaoying Hu, Yu Bai, Jianyang Liu, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 570-583
Open Access | Times Cited: 8

The Application of Biomaterials for the Vaccine, Treatment, and Detection of SARS-CoV-2
Yuan Hu, Lili Liu, Shenghua Zhang, et al.
ACS Omega (2024) Vol. 9, Iss. 5, pp. 5175-5192
Open Access | Times Cited: 6

Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans
Stephen J. Kent, Shiyao Li, Thakshila Amarasena, et al.
ACS Nano (2024)
Open Access | Times Cited: 5

Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5

Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
Xiaochun Bian, Liping Zhou, Zhiwei Luo, et al.
ACS Nano (2025)
Closed Access

Recent advances in mRNA‐based vaccine for cancer therapy; bench to bedside
Hadeel Ahmed Kenoosh, Harikumar Pallathadka, Ahmed Hjazi, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 4

Biomineralization strategy: from material manufacturing to biological regulation
Kexin Qin, Zitong Zheng, Jie Wang, et al.
Giant (2024) Vol. 19, pp. 100317-100317
Open Access | Times Cited: 4

Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
Yi Song, Jian Li, Yuzhang Wu
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4

Lung-Specific mRNA Delivery Enabled by Sulfonium Lipid Nanoparticles
David O. Popoola, Zhi Cao, Yuqin Men, et al.
Nano Letters (2024) Vol. 24, Iss. 26, pp. 8080-8088
Closed Access | Times Cited: 3

Nucleic acids in modern molecular therapies: A realm of opportunities for strategic drug design
Vito Genna, Laura Reyes-Fraile, Javier Iglesias‐Fernández, et al.
Current Opinion in Structural Biology (2024) Vol. 87, pp. 102838-102838
Closed Access | Times Cited: 2

mRNA vaccine development and applications: A special focus on tumors (Review)
Bangjie Chen, Yipin Yang, Xinyi Wang, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 2
Closed Access | Times Cited: 2

Noble Nanomedicine: Celebrating Groundbreaking mRNA Vaccine Innovations
Warren C. W. Chan, Natalie Artzi, Chunying Chen, et al.
ACS Nano (2023) Vol. 17, Iss. 20, pp. 19476-19477
Closed Access | Times Cited: 6

Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy
Theodora Katopodi, Savvas Petanidis, Eirini Grigoriadou, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 455-455
Open Access | Times Cited: 1

Modeling the cell biology of monogenetic intestinal epithelial disorders
Izumi Kaji, Jay R. Thiagarajah, James R. Goldenring
The Journal of Cell Biology (2024) Vol. 223, Iss. 7
Open Access | Times Cited: 1

Nanoimaging of SARS-CoV-2 viral invasion toward the nucleus and genome
Elma Sakinatus Sajidah, Keesiang Lim, Masaharu Hazawa, et al.
Cell Reports Physical Science (2024) Vol. 5, Iss. 9, pp. 102111-102111
Open Access | Times Cited: 1

Size-Controllable and Monodispersed Lipid Nanoparticle Production with High mRNA Delivery Efficiency Using 3D-Printed Ring Micromixers
Jiwoo Hong, Sanghun Lee, Hyochan Park, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 35, pp. 46044-46052
Closed Access | Times Cited: 1

Poly(β-amino ester) polymer library with monomer variation for mRNA delivery
Hong Lyun Kim, Gurusamy Saravanakumar, Seowon Lee, et al.
Biomaterials (2024) Vol. 314, pp. 122896-122896
Closed Access | Times Cited: 1

Cholic acid-mediated targeting of mRNA-LNPs improve the mRNA delivery to Caco-2 cells
Toma Shinkai, Koki Ogawa, Tatsuaki Tagami, et al.
Journal of Nanoparticle Research (2024) Vol. 26, Iss. 11
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top